icon 11630 SW 97 Street, Miami, Florida 33176, US

Tag: Bioinformatic

Ardigen and DKFZ research groups are entering into a collaboration to evaluate the safety of TCR-based therapies (TCR-Ts)

Press Release

Ardigen, a global leader in artificial intelligence & bioinformatics for precision medicine, announces its collaboration with the DKFZ research groups, led by Prof. Michael Platten/ Dr. Edward Green, regarding safety assessments of TCR based therapies (TCR-Ts). As a part of […]

Read More>>

Lukasz Dutkiewicz, PhD has joined Ardigen as a Business Development Director of the Digital CRO division to support global expansion

Press Release

  March 24, 2022 – Ardigen, a global leader in artificial intelligence for drug discovery, is proud to announce that Lukasz Dutkiewicz, PhD has joined the company as Business Development Director of the Digital CRO division. He brings extensive knowledge […]

Read More>>

Prof. Olivera Finn joined Ardigen’s Scientific Board to support the development of AI-driven technology platforms for cancer vaccines and cell therapies.

Press Release

Krakow, Poland, 04.11.2021. Ardigen, one of the world’s leading companies that utilizes artificial intelligence (AI) algorithms for drug discovery, announced that another distinguished scientist joined the company’s Scientific Advisory Board. Prof. Olivera Finn will support Ardigen’s work on AI-driven technology […]

Read More>>

Ardigen has received funding for development of AI-powered Microbiome Platform.

Press Release

Ardigen received funding for development of AI-powered Microbiome Platform that will improve prediction of cancer therapies efficacy. Krakow, Poland, 25.10.2021. Ardigen- the world-leading company that utilizes Artificial Intelligence (AI) for drug discovery, has signed an agreement with the Polish National […]

Read More>>

Dr. Aleksandra Walczak joined Ardigen’s Scientific Board to support the development of AI platforms for the discovery of cell therapies.

Press Release

September 7, 2021 – Ardigen, one of the world-leading companies that utilizes artificial intelligence (AI) algorithms for drug discovery, is proud to announce that Dr. Aleksandra Walczak joined the company’s Scientific Council. With a PhD in physical sciences and her […]

Read More>>

Ardigen promotes Michal Warchol to the Management Board to strengthen AI expertise in the field of drug discovery.

Press Release

March 11, 2021 – Ardigen, a global leader in artificial intelligence for drug discovery, is proud to announce that Dr. Michał Warchoł has joined the company’s Board of Management as its 4th member. He brings extensive knowledge and experience in the […]

Read More>>